Salience Clinical, LLC
Advances in molecular diagnostics, computational neuroscience, fluid biomarkers, and digital phenotyping are enabling CNS disorders to be reclassified according to biological signatures, neural circuit dysfunction, and measurable disease trajectories. Precision neurology is no longer a future concept; it is becoming the operational foundation of successful CNS development strategy.
https://salienceclinical.com/
Advances in molecular diagnostics, computational neuroscience, fluid biomarkers, and digital phenotyping are enabling CNS disorders to be reclassified according to biological signatures, neural circuit dysfunction, and measurable disease trajectories. Precision neurology is no longer a future concept; it is becoming the operational foundation of successful CNS development strategy.
https://salienceclinical.com/
Salience Clinical, LLC
Advances in molecular diagnostics, computational neuroscience, fluid biomarkers, and digital phenotyping are enabling CNS disorders to be reclassified according to biological signatures, neural circuit dysfunction, and measurable disease trajectories. Precision neurology is no longer a future concept; it is becoming the operational foundation of successful CNS development strategy.
https://salienceclinical.com/